Stock Ratings / Technology / ZEPP / forecast

OSS (47) SCKT (40) XNDU (49) OMCL (61) ⌘ Pro Terminal →

Zepp Health Corporation each representing sixteen (Class A) (ZEPP) 12-Month Stock Forecast & Price Target Cone

Q: Is ZEPP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Zepp Health Corporation each representing sixteen (Class A) (NYSE: ZEPP) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $2.25 (-3.85% 1D, market cap $33.0M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 5/20. Across 714 tracked Technology issuers, ZEPP ranks #624 in composite RQD confidence.

Q: How does ZEPP compare to OSS and SCKT in the Technology sector?

Within the Technology sector (Computer Manufacturing), ZEPP carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 38.3%, and ROIC of -14.7%. By comparison, OSS (One Stop Systems Inc.) holds a D grade (47/100 RQD, P/E 28.6x, ROIC -18.0%, cap $145.7M) and SCKT (Socket Mobile Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $3.0M). Among the 5-stock peer group, OSS leads on earnings multiple (28.6x) while OMCL leads on capital efficiency (0.4% ROIC).

Q: What are the biggest fundamental strengths and SEC risk factors for ZEPP?

Per ZEPP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001720446), Zepp Health Corporation each representing sixteen (Class A) generated $258.9M in revenue (+41.8% YoY), -$40.1M in net income, and -$26.2M in free cash flow against $564.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Q: Where is ZEPP trading relative to its 50-day, 200-day, and 52-week technical levels?

ZEPP last traded at $2.25 (-3.85% on volume of 68,747 shares), positioning the stock -43.18% below its 50-day simple moving average ($3.96) and -77.88% below its 200-day simple moving average ($10.17). Across its 52-week range of $2.15 to $42.35, ZEPP sits at the 0.2% percentile with a 14-day RSI of 11.4 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.97 to $2.53).

Q: Is ZEPP stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates ZEPP D- (Sell — SELL) with an RQD Confidence score of 35/100.

$2.25 -3.85% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.23

Zepp Health Corporation each representing sixteen (Class A) (ZEPP) carries a Roarable Rating of D- (Sell) with 35/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (35/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $33.0M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $2.23 (-0.88%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 3/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (35/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.5% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-10.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ZEPP)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (35/100 Composite)

🔍 WHY ZEPP SCORES 35/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+13/20 pts (37% of score)

FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 12 (OVERSOLD (<32))

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (23% of score)

Altman Z-Score 0.33 (DISTRESS RISK (<1.8)) • Piotroski F-Score 5/9

▼ #1 Drag / Risk Factor: Cash Engine Quality4/20 pts (-16 pt drag)

Capital intensity & 0% operating margin leave 16 pts on the table

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$3.72-18.8% Next Q

Q2 (-2Q)

Grade D$3.02-13.6% Next Q

Q3 (-1Q)

Grade E$2.61-13.8% Next Q

Current

Grade D-$2.25-8.5% Hist 90D α

Trajectory: D (43) → D- (35)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a ZEPP Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While ZEPP currently carries a cautious 35/100 (D-) rating due to Cash Engine Quality (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Technology with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.96) and Max Pain ($2.36) forces dealer call-delta covering toward $44.47.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ZEPP• $4.8M Crowd Pool • Kalshi / Polymarket Composite

Contract: “ZEPP Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”

YES 35%NO 65%Trade / Inspect Odds →

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your ZEPP Position Size: $10,000

Shares at $2.25: 4444.4 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $1.58

$7,022

$-2,978 (-29.8%)

12M Consensus BaseTarget $2.02

$8,978

$-1,022 (-10.2%)

12M Bull Case BreakoutTarget $44.47

$197,644

+$187,644 (+1876.4%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (35 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 9

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$2	74%	A
Goldman SachsSector Coverage Lead	UNDERPERFORM	$42	69%	B
JP MorganUS Large-Cap Research	SELL	$2	58%	C

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ZEPP)

✓Walkthrough of ZEPP's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ZEPP // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -87.12%🛡️ HOLDING TREND SUPPORT

2026-10-30O $2.16H $2.25L $2.15C $2.25VOL 112.6K

RES: $6.64SUP: $1.76SMA50: $3.96SMA200: $10.17

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ZEPP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ZEPP Butterfly Map → + Track ZEPP →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +41.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ZEPP today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ZEPP. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ZEPP today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ZEPP)

Technology Rank #624 of 714 ⚔️ OSS vs ZEPP Full Matrix →

1. Head-to-Head Technology Peer Comparison (ZEPP vs. OSS, SCKT, XNDU, OMCL)

Industry: Computer Manufacturing (9 Tracked Issuers)

Across 714 tracked Technology securities in the Roarable RQD universe, Zepp Health Corporation each representing sixteen (Class A) (ZEPP) ranks #624 by composite RQD confidence (35/100, grade D-) and #584 by equity capitalization ($33.0M). Within this direct 5-issuer industry benchmark cohort, OSS leads on earnings valuation at 28.6x trailing P/E, while OMCL leads on capital efficiency and profitability with 0.4% ROIC and 42.5% gross margin. OMCL currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with ZEPP at 35/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ZEPP ACTIVE Zepp Health Corporation each representing sixteen (Class A)	D-	35/100	—	38.3%	-14.7%	-3.85%	$33.0M	Benchmark Subject
OSS One Stop Systems Inc.	D	47/100	28.6x	49.6%	-18.0%	-6.88%	$145.7M	/oss-vs-zepp →
SCKT Socket Mobile Inc.	D-	40/100	—	49.7%	-35.0%	+5.94%	$3.0M	/sckt-vs-zepp →
XNDU Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares	D	49/100	—	—	—	-3.11%	$946.1M	/xndu-vs-zepp →
OMCL Omnicell Inc. ($0.001 par value)	C-	61/100	—	42.5%	0.4%	+2.59%	$1.68B	/omcl-vs-zepp →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001720446

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Zepp Health Corporation each representing sixteen (Class A) (ZEPP) reported GAAP revenue of $258.9M (+41.8% vs. FY2024 revenue of $182.6M , and -26.6% cumulative change since FY2023) , GAAP net income of -$40.1M, operating cash flow of -$25.7M, and free cash flow of -$26.2M (-1.6% YoY). On the balance sheet, ZEPP closed FY2025 with $564.8M in total assets against $0 in total debt (Altman Z-Score: 0.33, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$258.9M	-$40.1M	-$25.7M	-$26.2M	$564.8M	—
FY2024 (FY)	2024-12-31	$182.6M	-$75.7M	-$24.4M	-$25.8M	$528.6M	—
FY2023 (FY)	2023-12-31	$352.9M	-$31.0M	$42.6M	$42.6M	—	—

3. ZEPP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ZEPP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Zepp Health Corporation each representing sixteen (Class A) (NYSE: ZEPP) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $2.25 (-3.85% 1D, market cap $33.0M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 5/20. Across 714 tracked Technology issuers, ZEPP ranks #624 in composite RQD confidence.

How does ZEPP compare to OSS and SCKT in the Technology sector?

Within the Technology sector (Computer Manufacturing), ZEPP carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 38.3%, and ROIC of -14.7%. By comparison, OSS (One Stop Systems Inc.) holds a D grade (47/100 RQD, P/E 28.6x, ROIC -18.0%, cap $145.7M) and SCKT (Socket Mobile Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $3.0M). Among the 5-stock peer group, OSS leads on earnings multiple (28.6x) while OMCL leads on capital efficiency (0.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ZEPP?

Per ZEPP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001720446), Zepp Health Corporation each representing sixteen (Class A) generated $258.9M in revenue (+41.8% YoY), -$40.1M in net income, and -$26.2M in free cash flow against $564.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ZEPP trading relative to its 50-day, 200-day, and 52-week technical levels?

ZEPP last traded at $2.25 (-3.85% on volume of 68,747 shares), positioning the stock -43.18% below its 50-day simple moving average ($3.96) and -77.88% below its 200-day simple moving average ($10.17). Across its 52-week range of $2.15 to $42.35, ZEPP sits at the 0.2% percentile with a 14-day RSI of 11.4 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.97 to $2.53).

ZEPP Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is ZEPP's 12-month stock price target?

Zepp Health Corporation each representing sixteen (Class A) (ZEPP) carries a 12-month consensus base price target of $2.02 (-10.2% from $2.25), with a bull-case target of $44.47 and a bear-case floor of $1.58.

Is ZEPP stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates ZEPP D- (Sell — SELL) with an RQD Confidence score of 35/100.

Direct Sub-Reports: ZEPP RQD Cockpit ZEPP 12M Forecast ZEPP Earnings & Move ZEPP Dividends & DRIP ZEPP Insiders & 13F ZEPP Whale Options ZEPP Profit Sankey ZEPP News & Why